| European Case Law Identifier: | ECLI:EP:BA:2002:T035198.20020115 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 15 January 2002 | ||||||||
| Case number: | T 0351/98 | ||||||||
| Application number: | 85307860.8 | ||||||||
| IPC class: | C12N 15/48 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome | ||||||||
| Applicant name: | CHIRON CORPORATION | ||||||||
| Opponent name: | Biotest AG F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft British Bio-technology Limited Murex Biotech Limited Akzo Pharma B.V. Dade Behring Marburg GmbH IMMUNO Aktiengesellschaft |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Main request: added subject-matter (no), broadening of scope (no) sufficiency of disclosure (yes), right to priority (yes) Novelty (yes), Inventive step (yes) |
||||||||
| Catchwords: |
Disclaimer based solely on Article 54(3) EPC prior art document held allowable (see point 45), contrary to view expressed in decision T 323/97. |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t980351eu1.html
Date retrieved: 17 May 2021